CONJUGATED HEPCIDIN MIMETICS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 11, 2024
app pub date -
Mar 31, 2022
filing date -
Apr 1, 2021
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention generally relates to peptide analogues, including both monomers and dimers, exhibiting hepcidin activity with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof in the treatment and/or prevention of conditions or disorders, including erythrocytoses, such as polycytemia vera, iron overload diseases such as hereditary hemochromatosis: iron-loading anemias, and other conditions and disorders.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully